What is Wall Street’s target price for MEI Pharma Inc (MEIP) stock on Tuesday?
Wall Street is positive on MEI Pharma Inc (MEIP). On average, analysts give the stock a Strong Buy rating. The average price target is $9.833, which means analysts expect the stock to climb 353.13% over the next twelve months. This average ranking gives the stock an analyst rating of 73, which is better than 73% of stocks based on data compiled by InvestorsObserver.
Why are analyst ratings important?
You can learn a lot about a company by looking at its financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research. They usually follow a particular sector or industry very closely. They also pay attention and ask questions during earnings conference calls and other events where they might learn information that appears in the numbers.
InvestorsObserver takes the average rating of these analysts and then ranks these averages into percentiles. This allows you to compare stocks in a much more granular way than just seeing the typical five-tier rating system used across much of Wall Street.
What’s going on with MEI Pharma Inc stock today?
MEI Pharma Inc (MEIP) stock is trading at $2.17 at 3:16 p.m. on Tuesday, February 15, up $0.14, or 7.18% from the previous closing price of 2, $02. The stock has traded between $2.02 and $2.17 so far today. Volume today is 886,541 compared to an average volume of 1,025,414. Click here for the full MEI Pharma Inc. stock report.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.